72 Biggest Movers From Friday

Author: Lisa Levin | December 14, 2020 05:35am

Gainers

AbCellera Biologics Inc. (NASDAQ:ABCL) shares jumped 194.5% to close at $58.90 after the company priced its IPO at $20 per share.
TPG Pace Beneficial Finance Corp. (NYSE:TPGY) shares climbed 116.2% to close at $24.00 on Friday following a merger deal with EV charging company EVBox Group.
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) gained 76.1% to close at $40.50 after pricing its IPO at $23 per share.
Certara, Inc. (NASDAQ:CERT) gained 65.6% to close at $38.08 as the company priced its IPO at $23 a share.
Solid Biosciences Inc. (NASDAQ:SLDB) jumped 51.6% to close at $5.61 after the company announced a $90 million private placement of 24.3 million shares at $3.70 per share.
Vivos Therapeutics, Inc. (NASDAQ:VVOS) surged 49.8% to close at $8.99 after the company priced its IPO at $6 per share.
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) gained 42.7% to close at $11.54.
vTv Therapeutics Inc. (NASDAQ:VTVT) surged 41.6% to close at $3.10 following news Ron Perelman's MacAndrews & Forbes purchased 625,000 shares of company stock.
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) shares surged 41.3% to close at $8.76 as the company announced an agreement with Crown Laboratories, a skin care company, for the exclusive rights to sell and market Sonoma's products for the over-the-counter dermatological market in the U.S.
NextDecade Corporation (NASDAQ:NEXT) gained 38% to close at $3.45.
Recro Pharma, Inc. (NASDAQ:REPH) gained 36.8% to close at $2.9550.
FAT Brands Inc. (NASDAQ:FAT) shares jumped 28.1% to close at $7.89 after the company agreed to merge with Fog Cutter Capital Group.
Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) gained 24% to close at $1.50. Ampio entered into collaborative research agreements to explore additional clinical indications for its immunomodulatory drug, Ampion.
NantHealth, Inc. (NASDAQ:NH) rose 22.4% to close at $3.44. NantHealth recently presented significant treatment insights at the 2020 San Antonio Breast Cancer Symposium in a time of need with the pandemic’s impact on cancer care.
Torchlight Energy Resources, Inc. (NASDAQ:TRCH) climbed 19.7% to close at $0.7600 after climbing over 11% on Thursday.
Atento S.A. (NYSE:ATTO) surged 19.4% to close at $12.72.
Progenity, Inc. (NASDAQ:PROG) gained 19.1% to close at $4.73 after surging 14% on Thursday.
Allied Esports Entertainment Inc. (NASDAQ:AESE) jumped 19% to close at $1.44. Allied Esports Entertainment, last month, posted a Q3 loss.
Eargo, Inc. (NASDAQ:EAR) surged 18.7% to close at $56.98.
22nd Century Group, Inc. (NYSE:XXII) gained 18.1% to close at $2.54.
Evelo Biosciences, Inc. (NASDAQ:EVLO) shares jumped 17.6% to close at $7.54. Evelo Biosciences, last week, reported new clinical candidate in oncology.
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) gained 17.4% to close at $13.00.
Translate Bio, Inc. (NASDAQ:TBIO) surged 16.3% to close at $25.09.
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) gained 15.5% to close at $2.69.
Molecular Templates, Inc. (NASDAQ:MTEM) surged 15.4% to close at $9.96.
Mammoth Energy Services, Inc. (NASDAQ:TUSK) gained 15.2% to close at $4.09.
Vaxcyte, Inc. (NASDAQ:PCVX) shares rose 14.9% to close at $31.00.
MDJM Ltd. (NASDAQ:MDJH) surged 14.6% to close at $4.01.
The Walt Disney Company (NYSE:DIS) climbed 13.6% to close at $175.72. Walt Disney, during its Investor Day 2020, said streaming platform Disney+ hit 86.8 million subscribers. The streaming platform also announced plans to add something new every week with dozens of branded series heading to the streaming platform.
Ardelyx, Inc. (NASDAQ:ARDX) climbed 13.2% to close at $6.68 after SVB Leerink maintained an Outperform rating on the stock and raised its price target from $11 to $14. Ardelyx Director David Mott also purchased 170,000 shares at average price of $5.89 per share.
Inseego Corp. (NASDAQ:INSG) gained 12.2% to close at $13.76. The company on Thursday announced its 5G MiFi M2000 mobile hotspot is now available at T-Mobile and on Friday announced the availability of 5G MiFi M200 in Japan.
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) shares climbed 11.7% to close at $4.57 after the company received positive CHMP opinion for Ogluo™, its ready-to-use glucagon for injection, for the treatment of severe hypoglycaemia.
NantKwest, Inc. (NASDAQ:NK) climbed 11.7% to close at $12.35.
Tricida, Inc. (NASDAQ:TCDA) gained 9.8% to close at $7.51.
LiveXLive Media, Inc. (NASDAQ:LIVX) gained 9.2% to close at $2.84. LiveXLive Media, on Thursday, reported a 2 million share buyback program.
Novavax, Inc. (NASDAQ:NVAX) climbed 8.5% to close at $124.88.
Barnwell Industries, Inc. (NYSE:BRN) rose 7.9% to close at $1.37 after reporting Q4 results.
aTyr Pharma, Inc. (NASDAQ:LIFE) shares gained 7.9% to close at $4.64 after gaining over 6% on Thursday.
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) gained 7.5% to close at $0.69.
Forum Merger III Corporation (NASDAQ:FIII) rose 6.5% to close at $12.49.
Johnson Outdoors Inc. (NASDAQ:JOUT) rose 5.8% to close at $95.77 after reporting upbeat quarterly results.

Check out these big penny stock gainers and losers

Losers

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) shares tumbled 52.6% to close at $8.37 on Friday after the company reported follow-up data from a randomized Phase 2 VADIS trial of Nelipepimut-S in woman with ductal carcinoma in-situ of the breast. The company’s stock jumped 176% on Thursday.
Immutep Limited (NASDAQ:IMMP) fell 38.7% to close at $3.49. Immutep shares climbed 165% on Thursday after the company said its Chinese partner, EOC Pharma will commence a new Phase 2 clinical trial of Immutep's eftilagimod alpha in up to 152 metastatic breast cancer patients in China.
ALX Oncology Holdings Inc. (NASDAQ:ALXO) fell 28.4% to close at $80.40 after gaining 37% on Thursday. ALX Oncology priced an upsized underwritten public offering of 2.38 million shares of its common stock at a price of $76 per share.
Nabriva Therapeutics plc. (NASDAQ:NBRV) dropped 28.2% to close at $2.44 after the company reported pricing of $15 million public offering.
Professional Diversity Network, Inc. (NASDAQ:IPDN) fell 25.7% to close at $1.50 after jumping around 35% on Thursday.
Aytu BioScience, Inc. (NASDAQ:AYTU) fell 22.8% to close at $6.28 on profit taking after the stock rallied following news of a merger with Neos Therapeutics.
Greenwich LifeSciences, Inc.. (NASDAQ:GLSI) dropped 22.5% to close at $56.00 after climbing over 26% on Thursday. Greenwich LifeSciences recently shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) fell 21.5% to close at $12.28.
Amplify Energy Corp. (NYSE:AMPY) fell 20.7% to close at $1.19 after the company reported secondary public offering of 8.55 million shares of common stock for selling stockholders.
Cortexyme, Inc. (NASDAQ:CRTX) dipped 19.6% to close at $29.60. Citigroup initiated coverage on Cortexyme with a Sell rating and announced a price target of $20.
Innate Pharma S.A. (NASDAQ:IPHA) declined 18.1% to close at $4.36.
Luminar Technologies Inc (NASDAQ:LAZR) fell 17.7% to close at $28.12.
GeoVax Labs, Inc (NASDAQ:GOVX) fell 16.9% to close at $3.50 after declining over 26% on Thursday.
Rubius Therapeutics Inc (NASDAQ:RUBY) dropped 16.9% to close at $6.39.
Quantumscape Corp (NYSE:QS) dipped 16% to close at $64.15.
Neos Therapeutics, Inc. (NASDAQ:NEOS) fell 15.3% to close at $0.6920. Neos Therapeutics shares jumped 48% on Thursday after the company and Aytu Biosciences announced a merger agreement.
Seritage Growth Properties (NYSE:SRG) fell 15.3% to close at $14.51 after announcing CEO transition.
Phio Pharmaceuticals Corp. (NASDAQ:PHIO) declined 14.8% to close at $2.83 after gaining over 29% on Thursday.
Napco Security Technologies, Inc. (NASDAQ:NSSC) declined 14% to close at $26.16 after the company priced its ~2.23 million shares common stock offering at $26 per share.
Monaker Group Inc (NASDAQ:MKGI) shares fell 13.4% to close at $3.10. Monaker Group raised instantly confirmable alternative lodging rental properties available through booking engine to over 3.4 million units.
The9 Limited (NASDAQ:NCTY) dipped 13.3% to close at $2.74.
Ideaya Biosciences Inc (NASDAQ:IDYA) fell 13.2% to close at $14.24.
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) dropped 12.9% to close at $7.24.
Boxlight Corporation (NASDAQ:BOXL) fell 12.8% to close at $1.70. Boxlight shares jumped 17% on Thursday after it was reported the CEO purchased 40,000 shares at an average price of $1.65 per share.
Cellect Biotechnology Ltd – ADR (NASDAQ:APOP) dropped 12.6% to close at $2.29.
9 Meters Biopharma, Inc. (NASDAQ:NMTR) shares fell 11.8% to close at $0.75. 9 Meters Biopharma shares recently received Orphan Drug Designation for NM-003.
Panbela Therapeutics Inc. (NASDAQ:PBLA) declined 11.6% to close at $3.98 after gaining 5% on Thursday. The company recently reported completion of enrollment in Phase 1b trial investigating SBP-101 combo therapy for first line metastatic pancreatic cancer.
Moxian, Inc. (NASDAQ:MOXC) fell 9.9% to close at $1.36 following a 20% surge on Thursday.
Marathon Patent Group, Inc. (NASDAQ:MARA) shares fell 9% to close at $4.75 after gaining 9% on Thursday. Marathon Patent Group recently purchased additional 10K S-19j Pro ASIC miners from Bitmain and announced plans to open a second data center.
NatWest Group plc (NYSE:NWG) fell 7.9% to close at $3.94. NatWest Group filed for a mixed shelf offering.
NIO Limited (NYSE:NIO) fell 7.2% to close at $41.98 after the company reported a proposed offering of 60,000,000 American Depositary Shares.